Toronto · Independent Shariah screening · Updated daily
Guide · Researched from official sources · Content-only (no affiliate programs)

Are Uranium Stocks Halal? Screening Cameco, Kazatomprom, and the Nuclear Fuel Chain (2026)

Cameco passes this site's Shariah screen — and it is one of the most-read screeners on the site. Uranium mining and nuclear fuel services are a permissible business under the screen, and Cameco's debt and non-compliant income sit well inside the financial ceilings. But most uranium stocks do not pass: of the uranium miners and explorers screened on this site, only a handful clear both gates, and the world's largest uranium producer has not been screened here at all. This guide works through the whole question — the dual-use problem, the fuel chain step by step, every uranium screener result on the site, and the checklist a Canadian investor should run before buying.

Updated November 2026 · 13-minute read · Reviewed by the Canadian Halal Investor team

Why uranium raises a Shariah question at all

Uranium is the only commodity where the halal question starts before the financial statements. With most stocks, the screen is mechanical: what does the company do, and do its ratios clear the ceilings? With uranium, the first question is philosophical — is mining the raw material of nuclear power the same as being in the weapons business?

The question has a real-world edge for Canadians. Saskatchewan holds some of the highest-grade uranium deposits on earth, and Cameco — headquartered in Saskatoon — is one of the world's largest uranium producers and one of this site's most-read screener pages. At the same time, nuclear power supplies about 9% of the world's electricity, the International Energy Agency expects global nuclear capacity to grow by at least one-third by 2035, and 38 countries have backed an ambition to triple nuclear capacity by 2050. Uranium is not a fringe theme any more; it is the fuel of a power source that governments are actively expanding, including to power the data centres behind artificial intelligence. A halal investor who ignores it is ignoring a real corner of the market — and one who buys it without screening it is buying blind.

The discomfort is easy to state. Uranium is the feedstock for both nuclear reactors and nuclear weapons. The same element that lights a city can, enriched far enough, destroy one. That dual-use nature is what makes investors pause, and it is the reason this guide starts with the physics and the law before it touches a balance sheet. The screen itself, as the next section shows, draws a narrower line than the discomfort suggests — but the discomfort is worth understanding on its own terms, because it is the reason some investors will still say no even after a stock passes.

Gate one: is uranium mining a prohibited business?

Every screener on this site applies the same two-gate screen, documented on our methodology page, using the 33%/33%/5% thresholds of the Dow Jones Islamic / S&P Shariah convention. Gate one looks at what the company does. A company fails it if its core business is in an industry widely considered non-compliant under AAOIFI-style screening: conventional financial services, alcohol production and distribution, gambling and casinos, pork production and processing, adult entertainment, conventional weapons manufacturing, tobacco production, and derivatives and speculative trading venues.

Uranium mining is not on that list. Neither is nuclear power generation, uranium refining, conversion, or fuel fabrication. The methodology assesses what the company actually does — its revenue-generating operations as disclosed in its own filings — not just its industry label. On that basis, the site's Cameco screener states the conclusion plainly: "Uranium mining and nuclear fuel services are a permissible business." That is the screen's answer, and it is why Cameco's result turns on its ratios rather than its industry.

The weapons-manufacturing exclusion is where the argument lives. A company that builds warheads, missiles, or combat systems fails gate one outright. A company that digs uranium out of the ground in Saskatchewan does not — because what it sells is not a weapon. The uranium it mines cannot be used as a weapon in the form it sells it: natural uranium contains about 0.7% of the fissile isotope U-235, far too little to sustain a chain reaction. It must be enriched — concentrated — before it can fuel a reactor, and enriched far further before it can arm a weapon. Fuel for power reactors is typically enriched to about 3 to 4% U-235. Weapons-grade material is over 90%. The gap between those two numbers is the whole dual-use debate in one fact.

None of that makes the question disappear. Three gray areas sit on the boundary, and each is worth naming:

Scholars disagree on the wider question, and this page reports the disagreement rather than settling it. Some investors treat any involvement in the nuclear fuel chain as too close to weapons to hold, on the principle that the end use is ultimately unknowable. Others — and the major Shariah index methodologies — treat civilian nuclear fuel as a permissible industrial activity, screened on its financials like any other mining or energy business. There is no published fatwa specific to uranium mining that this site can cite as settling the matter, and none is claimed here. The screen's result is a methodology output; your decision is your own, and a qualified scholar is the right person to take it to. See our Ask a Scholar page.

Shariah callout: the screen is not a fatwa. A PASS result means the company cleared this site's two-gate screen — business activity, then financial ratios. It is not a religious ruling on your investment, and it does not settle the dual-use question for you. The disagreement about uranium's weapons-adjacent nature is real and reported above; nothing on this page picks a side. Not financial advice. Facts and screening methodology only — no fatwas.

The nuclear fuel chain, step by step

To screen a uranium company you have to know where it sits in the chain, because the chain — not the mine alone — is the business. Uranium reaches a reactor in six steps, and different companies occupy different ones:

  1. Mining. Ore is dug up, usually by open pit, underground mining, or in-situ recovery — pumping a solution underground to dissolve the uranium and bring it to the surface. Most Canadian juniors live here, and only here.
  2. Milling. Ore is crushed and chemically treated to produce uranium concentrate, commonly called yellowcake (U3O8). Cameco mills at Key Lake and McClean Lake in Saskatchewan.
  3. Refining. Yellowcake is purified into uranium trioxide (UO3). Cameco's Blind River refinery in Ontario is the world's largest commercial uranium refinery.
  4. Conversion. UO3 is converted into uranium hexafluoride (UF6), the feedstock for enrichment, or into uranium dioxide (UO2) for Canada's CANDU reactors. Cameco's Port Hope facility is Canada's only uranium conversion facility and the world's only commercial supplier of natural UO2 for CANDU fuel.
  5. Enrichment. UF6 is enriched to raise the U-235 concentration to the 3 to 5% used in light-water reactors. Cameco's exposure here is its 49% stake in Global Laser Enrichment; it does not operate a commercial enrichment plant itself.
  6. Fuel fabrication and reactors. Enriched uranium is made into fuel assemblies, and the assemblies power reactors. Cameco fabricates CANDU fuel at Port Hope and, through its 49% ownership of Westinghouse alongside Brookfield, participates in reactor supply, fuel, and services worldwide.

Cameco's position is unusual: it is present at almost every step, from its McArthur River and Cigar Lake mines — among the highest-grade uranium orebodies on earth — through refining, conversion, and fabrication, and into reactors through Westinghouse. Its own filings describe contracts to sell about 220 million pounds of U3O8 to 41 customers worldwide and about 85 million kilograms of UF6 conversion services to 34 customers, selling uranium and fuel services to nuclear utilities in 16 countries. That integration is the investment case in a sentence: it is not a bet on one mine, it is a bet on the fuel cycle. It is also what makes the screen interesting — a company this integrated has more places for a gray area to hide, and each one has to be checked.

Kazatomprom sits at the other end of the scale: a miner, not an integrator. It operates 27 deposits grouped into 14 mining assets across Kazakhstan, all using in-situ recovery, and sells uranium and uranium products mainly to nuclear power plant operators under long-term contracts. It produced 25,839 tonnes of uranium in 2025 on a 100% basis — about 20% of global primary production — in a country that supplies about 40% of the world's mined uranium. The two companies barely overlap: Cameco is the largest Western producer and the integrated fuel-cycle player; Kazatomprom is the largest producer outright and a pure miner. A Canadian investor comparing them is comparing two different businesses that happen to sell the same element.

What the screeners actually say: every uranium name on this site

The screeners tell a consistent story: the business is rarely the problem, the financials are. Here is every uranium miner and explorer this site has screened, with the result and the reason:

CompanyListingResultWhy
CamecoTSX: CCO / NYSE: CCJPASSProducing miner and fuel-cycle company. Debt ~2.2% of market cap, finance income ~1.1% of revenue — both well inside the ceilings.
NexGen EnergyTSX: NXEPASS*Pre-production explorer. Debt clears the ceiling comfortably, but with nil revenue the ~5% income gate cannot be computed — provisional pass, marked with an asterisk on the screener.
Mega UraniumTSX: MGAPASSSmall explorer/investment company that cleared both gates on its screening date.
Stallion UraniumTSXV: STUDPASSEarly-stage explorer that cleared both gates on its screening date.
Denison MinesTSX: DMLFAILDevelopment-stage miner. Interest income of ~170.5% of fiscal 2025 revenue — the income gate fails by a wide margin.
Energy FuelsTSX: EFR / NYSE American: UUUUFAILInterest income of US$15.148 million was ~24.9% of first-half 2026 revenue of US$60.946 million — over the ~5% ceiling. Rare-earth defence-market exposure is also disclosed as a gray area.
enCore EnergyTSXV / NASDAQ: EUFAILPure-play uranium producer with a clean business and interest income inside the ceiling — but interest-bearing debt of ~US$113.5 million is ~55.7% of its ~US$203.9 million market cap, above the ~33% ceiling.
F3 UraniumTSXV: FUUFAILExplorer that failed the financial gates on its screening date.
Purepoint UraniumTSXV: PTUFAILExplorer that failed the financial gates on its screening date.

Two patterns jump out. First, the only established producer in the list passes, and the only other passes are small explorers whose balance sheets happened to be clean on their screening dates — a pass for a pre-revenue explorer is fragile by nature, and NexGen's asterisk says so openly. Second, the failures split into two kinds: income failures (Denison, Energy Fuels — too much interest income against too little revenue) and debt failures (enCore — too much borrowing against too small a market value). Neither kind has anything to do with uranium as a business. The sector's problem is not that mining uranium is non-compliant; it is that most uranium companies are small, pre-revenue, or heavily indebted, and the financial gates are not kind to any of those.

One more note on the table: the site's moral screen currently publishes no findings on any of these uranium names — no documented ties to the Israeli military, the US military, or weapons manufacturing. That is a statement about what has been published, not a clean bill of health; the moral screen covers documented findings only, and its coverage of the sector is thin. The business gate and the moral screen are separate checks, and neither substitutes for the other.

Gate two: why so many uranium juniors fail

The 5% non-compliant-income ceiling is the gate that kills most uranium juniors, and the mechanics are worth understanding because they explain why a company with a clean business can still fail. The ratio is non-compliant income — overwhelmingly interest income on cash balances — divided by total revenue. For a producing miner like Cameco, revenue is large and the ratio is small: about 1.1%. For a development-stage miner like Denison, revenue is near nil while the company still holds cash and earns interest on it. The numerator is ordinary; the denominator is almost zero; the ratio explodes. Denison's interest income was about 170.5% of its fiscal 2025 revenue — not because it earned an enormous amount of interest, but because it earned almost no revenue at all.

The same arithmetic bites explorers from the other side. A junior with no production and a small market capitalisation can fail the debt ceiling on a modest loan: enCore's ~US$113.5 million of debt is not large in absolute terms, but against a ~US$203.9 million market cap it is ~55.7%, well above the ~33% ceiling. And a pre-revenue company can fail the cash ceiling too — a large cash balance raised to fund exploration, divided by a small market cap, can clear 33% on its own.

This is not a flaw in the screen; it is the screen doing what it is designed to do. The financial gates exist to catch companies whose economics depend on interest — whether as income or as leverage — and a pre-revenue miner that lives on its cash pile and its credit line is, financially, an interest-dependent business even if its ore is perfectly permissible. The practical consequence for an investor is blunt: in the uranium sector, the screenable universe is essentially the producers. The juniors are a speculation on future production, and the screen will usually say so before the market does. Our guide on what to do when a halal stock fails the screen covers the exit discipline — a FAIL is a sell signal for the position, not a hold-and-hope.

There is a second-order effect worth flagging. Because so few uranium names pass, a halal investor who wants uranium exposure ends up concentrated: in practice, Cameco — plus the small, fragile explorer passes — is the screened universe. Concentration is a portfolio decision, not a screening result, and it deserves its own thought. Our rebalancing guide covers how to think about a position that grows to dominate a portfolio, and the semiconductor screening guide shows the contrast: a sector where nearly every major name passes, and concentration is a choice rather than a constraint.

Kazatomprom: the giant with no screener yet

The largest uranium producer in the world is the one name a Canadian investor cannot screen on this site — yet. Kazatomprom, Kazakhstan's national atomic company, produced about 20% of the world's primary uranium in 2025, and Kazakhstan as a country supplies about 40% of global mined uranium. It is, by output, roughly twice the scale of any Western producer. It is also state-controlled, it mines entirely by in-situ recovery across 27 deposits, and it sells mostly under long-term contracts to nuclear power plant operators.

Its shares trade as global depositary receipts on the London Stock Exchange and on the Astana International Exchange — not in Toronto or New York. That matters twice over for a Canadian investor. First, access: whether your broker offers the London listing, what the dealing costs are, and how the shares are held are questions to settle before any screening question arises. Second, screening: the financial gates need the company's latest financial statements, and a state-controlled miner reporting under IFRS with joint-venture structures needs the same careful read as any other company — the ratios are computable, but they are not trivially readable off a quote page.

What can be said now, without a screener result, is limited to the business gate. Kazatomprom mines uranium and sells it to power plant operators — the same permissible business activity as Cameco's mining segment. Nothing in its public description suggests a prohibited segment. But the business gate is only half the screen, and the financial gates — debt, cash, and non-compliant income against market capitalisation and revenue — cannot be asserted without running them. This site has not run them, so this guide reports no result for Kazatomprom. If you hold it or are considering it, the correct move is to screen it yourself using the methodology page and the company's latest published statements, or to wait for a screener to be published. Do not treat the absence of a FAIL as a PASS.

The same caution applies to the rest of the un-screened uranium world: the physical uranium trusts, the royalty companies, and the smaller producers that have not been through this site's screen. The uranium sector is small enough that the screened list above covers most of the names a Canadian broker will show you — but "most" is not "all," and an un-screened name is an unanswered question, not a clean one.

Uranium ETFs: screen the holdings, not the label

For many investors the natural response to a sector with one clear producer and a long tail of failures is to buy the basket instead: a uranium ETF. The instinct is reasonable and the execution needs care, because a fund does not inherit a screen result from its theme. A uranium fund is a basket of miners, developers, explorers, and sometimes utilities or physical uranium vehicles — and a basket that contains several FAIL names does not become compliant because the label on the tin says "uranium."

The method is the one in our guide on how to check a fund's holdings for halal compliance: pull the fund's published holdings list, screen the largest positions one by one against the two gates, and judge the fund on its holdings. In practice that means checking whether the fund's biggest weights are producers like Cameco — which passes — or a spread of juniors that mostly fail. A fund dominated by one passing producer and a tail of small failures is a different proposition from a fund spread evenly across failing explorers, and the holdings list is the only way to tell them apart.

Two further cautions. First, fund holdings change: a quarterly rebalance can swap a passing producer for a failing developer, so the check is not one-and-done. Second, some uranium vehicles hold physical uranium rather than shares — a trust that owns yellowcake is a different asset from a miner, and its compliance turns on the structure of the vehicle, not on a stock screen. If the fund's structure is not something you can explain in a sentence, that is itself information.

The Canadian investor's checklist

Before buying any uranium stock, run this checklist — it takes minutes and it catches the mistakes that cost money:

  1. Check the screen result. Look the ticker up on this site first. Cameco passes; Denison, Energy Fuels, enCore, F3, and Purepoint fail; NexGen is a provisional pass. If the name has not been screened, run the two gates yourself from its latest statements — do not buy on the theme alone.
  2. Check the listing and the account. Cameco trades in Toronto as CCO and in New York as CCJ. US-listed names carry different withholding-tax treatment by account — the US withholding rate is 15% inside a TFSA and treaty-exempt inside an RRSP — so the same share can have a different after-tax outcome depending on where you hold it. Our asset-location guide works through TFSA, RRSP, and non-registered placement in full.
  3. Plan the purification. A PASS holding can still earn a small amount of non-compliant income, and that income flows into your dividends. Cameco's finance income of about 1.1% of revenue is the figure to purify on — small, but not zero, and it belongs in your annual calculation. Our purification how-to shows the exact math.
  4. Size the position for a one-name sector. With essentially one established producer passing the screen, uranium exposure in a halal portfolio is concentrated by construction. Decide in advance what share of your portfolio one commodity name should be, and write it down before you buy — not after it doubles.
  5. Set the re-screening reminder. Screen results are dated. Cameco's numbers are from its September 2026 screening; a new debt issue, a revenue shock, or a change in the business — a bigger enrichment stake, a defence contract — can move a ratio across a ceiling. Re-check the screener before adding to a position, and at least annually for anything you hold.
  6. Keep the dual-use question separate from the screen. The screen answers whether the company passes a documented methodology. Whether you are personally comfortable holding a uranium miner is a separate question, and it is yours to answer — with a scholar if you want one. Do not let a PASS do your conscience's work for it, and do not let discomfort with the theme override a FAIL that is really about debt.

What to watch next

Three things would change this guide. The first is Kazatomprom: a published screener for the world's largest producer would complete the picture, and its financial gates are the open question — the business is straightforward, the ratios are not yet public in screened form. The second is Cameco's enrichment stake: the 49% interest in Global Laser Enrichment is small today, but enrichment is the step where the dual-use question is sharpest, and any expansion of that business deserves a fresh look at gate one. The third is the juniors: a developer that starts producing — Denison's Wheeler River project, NexGen's Rook I, enCore's pipeline — changes its revenue denominator overnight, and a company that fails today on near-nil revenue can pass tomorrow on real production. That is why the screeners are re-run rather than carved in stone, and why a FAIL today is a fact about the latest statements, not a verdict on the company forever.

The broader backdrop is the demand story: nuclear capacity is set to grow by at least one-third by 2035 on the International Energy Agency's outlook, 38 countries have backed tripling capacity by 2050, and about 65 reactors were under construction worldwide at the end of 2025. None of that is an investment case on its own — demand growth does not make a leveraged junior compliant — but it explains why the question keeps coming up, and why it will keep coming up. The screen is the filter; the demand story is the reason the filter matters.

Uranium, screened properly, is a narrow opportunity: one clear producer, a handful of fragile explorer passes, a long list of financial-gate failures, and the biggest producer in the world still un-screened. That narrowness is itself the finding. A halal investor who wants uranium exposure can get it — through Cameco, with purification planned and concentration understood — but the sector does not offer the broad, diversified menu that semiconductors do. Buy the screen result, not the theme.

FAQ

Is uranium mining halal?

Under the screening methodology this site applies, yes as a business activity: uranium mining and nuclear fuel services are a permissible business, and Cameco passes the screen. The methodology's business gate excludes conventional weapons manufacturing, alcohol, gambling, pork, adult entertainment, tobacco, conventional finance, and derivatives venues — uranium mining is not on that list. The question investors argue about is not the mining itself but the dual-use nature of uranium, covered in the first sections of this guide. This is a screening result, not a fatwa.

Why does Cameco pass the screen when other uranium stocks fail?

Cameco is a producing company with real revenue, so its ratios are computable and comfortable: interest-bearing debt of about 2.2% of market capitalisation against a roughly 33% ceiling, and finance income of about 1.1% of revenue against a roughly 5% ceiling. Most uranium juniors fail at the second gate, not the first — their business is clean, but with little or no revenue, even small amounts of interest income blow past the 5% ceiling, or their debt exceeds 33% of a small market capitalisation. Denison Mines, for example, fails because interest income was about 170.5% of its fiscal 2025 revenue.

Is investing in uranium the same as investing in nuclear weapons?

No — and the distinction is the core of the dual-use question. Natural uranium contains about 0.7% of the fissile isotope U-235. Fuel for power reactors is typically enriched to about 3 to 4% U-235, while weapons-grade material is over 90%. Civilian uranium moves under the Nuclear Non-Proliferation Treaty and International Atomic Energy Agency safeguards, and the World Nuclear Association states that no uranium traded for electricity production has ever been diverted for military use. What makes some investors uneasy is that the same element, enriched further, can become a weapon — so the line depends on end use and safeguards, not on the ore itself.

What about Kazatomprom, the world's largest uranium producer?

Kazatomprom produced about 20% of the world's primary uranium in 2025, with Kazakhstan supplying about 40% of global output — but it has not been screened on this site, so there is no PASS or FAIL result to report for it. Its shares trade as global depositary receipts on the London Stock Exchange and on the Astana International Exchange, and it is a state-controlled company. Any investor considering it would need to run the same two gates — business activity, then the debt, cash, and non-compliant income ratios — against its latest financial statements before buying.

Can I buy a uranium ETF instead of picking a miner?

You can, but the ETF does not inherit a screen result: a uranium fund is a basket, and each holding needs its own screen. Most uranium funds hold a mix of producers, developers, explorers, and sometimes utilities or physical uranium trusts, and a basket that includes several FAIL names does not become compliant because the theme is. The practical method is the one in the site's fund-holdings guide: pull the fund's holdings list, screen the largest positions one by one, and treat the fund as compliant only if its holdings are.

What should a Canadian investor check before buying a uranium stock?

Four things. First, the screen result on this site — or run the two gates yourself if the name has not been screened. Second, the listing: Cameco trades in Toronto as CCO and in New York as CCJ, and US-listed names carry different withholding-tax treatment by account — 15% in a TFSA, treaty-exempt inside an RRSP. Third, purification: a PASS holding can still earn a small amount of non-compliant income, and Cameco's finance income of about 1.1% of revenue is the figure to purify on. Fourth, re-screening: a PASS can turn FAIL when financials change, so check the screener again before adding to a position.

Affiliate disclosure. This page contains no affiliate links, and the site currently earns no affiliate revenue. If we join affiliate programs in the future, this disclosure will be updated and links will be clearly labeled. Commissions never influence our scores or rankings — this review is based on official documentation and public data, and every product is Shariah-screened before review. Nothing on this site is financial advice.